Orion BioScience, a Delaware corporation headquartered in Kansas City, Missouri, is a start-up stage biotechnology delivery company focusing on the development of two therapeutic modalities to ameliorate the devastating effects of autoimmune and antibody-mediated diseases and associated inflammation. Two of the co-founders of Orion, Dr. Joshua Sestak and Prof. Cory Berkland, have invented disruptive technologies that Orion is developing to provide both immediate relief and long-term solutions to human diseases.